Patents by Inventor Laurent Desaubry

Laurent Desaubry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120101153
    Abstract: The present invention discloses new rocaglaol derivatives and the use of rocaglaol derivatives to prevent or to limit the cardiotoxicity of an antineoplastic agent, in particular to prevent or to limit the apoptosis of cardiomyocytes induced by such agent.
    Type: Application
    Filed: November 24, 2009
    Publication date: April 26, 2012
    Applicant: Universite De Strasbourg
    Inventors: Laurent Desaubry, Gunsel Canan Desaubry, Thierry Cresteil, Gülen Türkeri
  • Patent number: 6132957
    Abstract: The present invention reveals a new series of derivatives and analogues of adenine and adenosine, i.e., 3'-adenosine derivatives, which inhibit adenylyl cyclase activity. These newly synthesized compounds include the most potent inhibitors of adenylyl cyclases known. The present invention also discloses a method for measuring the inhibition of adenylyl cyclase activity.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: October 17, 2000
    Assignee: The Research Foundation of State University of New York
    Inventors: Roger A. Johnson, Laurent Desaubry, Ilana Shoshani
  • Patent number: 5795756
    Abstract: The present invention reveals a new series of derivatives and analogues of adenine and adenosine, i.e., 3'-adenosine derivatives, which inhibit adenylyl cyclase activity. These newly synthesized compounds include the most potent inhibitors of adenylyl cyclases known. The present invention also discloses a method for measuring the inhibition of adenylyl cyclase activity.
    Type: Grant
    Filed: December 10, 1996
    Date of Patent: August 18, 1998
    Inventors: Roger A. Johnson, Laurent Desaubry, Ilana Shoshani